From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined

From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined

Dr. Andreas Reichl, Senior Drug Development Consultant, and Dr. Kevin Schaab, Senior Drug Development Consultant, both from Quotient Sciences, present a practical breakdown of how early-phase experts design programs to mitigate risks and efficiently move novel molecules into PoC assessments.

Watch Now

First Name *

Last Name *

Job Title *

Email Address *

Work Phone

Company *

Country *

Street Address

City

ZIP Code

Company Type

In what phase of development is your program? *

How soon are you looking to make a decision on a CRO partner? *

By downloading this content, you agree to MJH Life Sciences® Terms and Conditions, Privacy Policy, and understand your data will be used by MJH and its affiliates for amongst other things, alerting you to other services or products that you may be interested in, and may be shared with or sold to third parties for their use, including possible contact with you through email or other communications, consistent with their respective privacy policy. If you do not agree to have your data used in this way, please contact info@mjhassoc.com.

Please leave this field empty.